DE2150539A1 - Mittel gegen den befall von pferden durch dassel-larven - Google Patents
Mittel gegen den befall von pferden durch dassel-larvenInfo
- Publication number
- DE2150539A1 DE2150539A1 DE19712150539 DE2150539A DE2150539A1 DE 2150539 A1 DE2150539 A1 DE 2150539A1 DE 19712150539 DE19712150539 DE 19712150539 DE 2150539 A DE2150539 A DE 2150539A DE 2150539 A1 DE2150539 A1 DE 2150539A1
- Authority
- DE
- Germany
- Prior art keywords
- uie
- cii
- uiiu
- vii
- coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010061217 Infestation Diseases 0.000 title 1
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 claims 2
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- 229920001577 copolymer Polymers 0.000 claims 2
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 claims 1
- VNRJVVUVDYYTRO-UHFFFAOYSA-N 2-(trimethylazaniumyl)ethoxymethanedithioate Chemical compound C[N+](C)(C)CCOC([S-])=S VNRJVVUVDYYTRO-UHFFFAOYSA-N 0.000 claims 1
- 241000219823 Medicago Species 0.000 claims 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CBQYNPHHHJTCJS-UHFFFAOYSA-N Alline Chemical compound C1=CC=C2C3(O)CCN(C)C3NC2=C1 CBQYNPHHHJTCJS-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000257191 Oestridae Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940099990 ogen Drugs 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 231100000916 relative toxicity Toxicity 0.000 description 1
- 241000894007 species Species 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4558070A | 1970-06-11 | 1970-06-11 | |
| NL7113971A NL7113971A (en) | 1971-10-12 | 1971-10-12 | Anti botfly larvae compsn - contg choline xanthate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2150539A1 true DE2150539A1 (de) | 1973-04-19 |
Family
ID=26644688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712150539 Pending DE2150539A1 (de) | 1970-06-11 | 1971-10-11 | Mittel gegen den befall von pferden durch dassel-larven |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE774408A (enExample) |
| DE (1) | DE2150539A1 (enExample) |
| FR (1) | FR2158076B1 (enExample) |
| GB (1) | GB1297719A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8003805L (sv) * | 1980-05-21 | 1981-11-22 | Haessle Ab | En farmaceutisk beredning med forbettrade utlosningsegenskap |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2972613A (en) * | 1959-03-09 | 1961-02-21 | Dawe S Lab Inc | Cyclic choline xanthate |
-
1971
- 1971-10-11 DE DE19712150539 patent/DE2150539A1/de active Pending
- 1971-10-11 GB GB1297719D patent/GB1297719A/en not_active Expired
- 1971-10-25 BE BE774408A patent/BE774408A/xx unknown
- 1971-10-26 FR FR7138478A patent/FR2158076B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE774408A (fr) | 1972-02-14 |
| FR2158076B1 (enExample) | 1975-02-07 |
| GB1297719A (enExample) | 1972-11-29 |
| FR2158076A1 (enExample) | 1973-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Besco et al. | Foreman leadership as perceived by superiors and subordinates. | |
| CH356954A (de) | Verfahren zum Schützen von nichttextilen Materialien gegen Termitenfrass | |
| DE2150539A1 (de) | Mittel gegen den befall von pferden durch dassel-larven | |
| CH500177A (de) | Verfahren zur Herstellung von bis-Isothioharnstoffen | |
| AT326949B (de) | Insektizide mischung | |
| DE2109571B2 (de) | Analoga des lapachols | |
| ES8104802A1 (es) | Procedimiento de preparacion de agentes antifungicos sinergicos. | |
| DE2028828A1 (de) | Pyrazolopyridin carbonsauren und deren Derivate sowie Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE3026365A1 (de) | Neue tetrahydropyridin-4-yl-indol- derivate und deren salze, ihre herstellung, ihre verwendung als arzneimittel und die sie enthaltenden zusammensetzungen | |
| DE2613328A1 (de) | 1-methyl-2-(m-trifluormethyl-phenyl)- aethylamid der p-pentylamino-phenoxyessigsaeure, ein verfahren zu dessen herstellung sowie arzneimittel | |
| AT216522B (de) | Verfahren zur Herstellung des neuen N-3,4-Dimethylbenzolsulfonyl-N'-tetramethylenharnstoffs | |
| DE2242779A1 (de) | Chlorphenesinderivate, verfahren zu ihrer herstellung und ihre verwendung als oder in einem arzneimittel | |
| DE1542769A1 (de) | Akaricide mit ovicider und larvicider Wirkung | |
| DE2136929C3 (de) | Verwendung bestimmter 3',4'-Methylendioxiphenylpiperazine | |
| Chan et al. | Liver Carcinogencsis by Methyl Carbamate in F344 Rats and Not in B6C3F1 Mice | |
| DE1667937C3 (de) | Fungizide Mischung auf der Grundlage von Pentachlorphenol | |
| DE1235930B (de) | Verfahren zur Herstellung von als Heilmittel geeignetem 1-Phenyl-3-butyl-4-methyl-triazolon-(5) | |
| DE1518205C3 (de) | Anaplasmotische Arzneimittel | |
| AT208874B (de) | Verfahren zur Herstellung von neuen Carbaminsäureestern | |
| SU138158A1 (ru) | Состав дл сн ти слепков | |
| DE1204880B (de) | Selektives Herbizid | |
| Hashimoto | Ecological study of the Tree Sparrow Passer montanus 1. Age and sex identification | |
| DE1264772B (de) | Gegen Verfaerbung stabilisierte Formmassen aus Polyvinylchlorid | |
| DE1470156A1 (de) | Verfahren zur Herstellung von Azabenzocycloalkan-N-carboxamidinen und ihrer Saeureadditionssalze | |
| DE1181715B (de) | Verfahren zur Herstellung von 3-(ª‰-Amino-aethyl)-5-methoxy-cumaron-hydrochlorid |